BCKDK INHIBITORS

wherein R1, R2, and R3 are defined herein, their use as branched-chain alpha keto acid dehydrogenase kinase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetes, NASH and heart failure.

Saved in:
Bibliographic Details
Main Authors Miller, Russell Alan, Buzon, Leanne Marie, Kormos, Bethany Lyn, Griffith, David Andrew, Filipski, Kevin James, Zhang, Yuan, Bhattacharya, Samit Kumar, Roth Flach, Rachel Jane, Martinez-Alsina, Luis Angel, Reese, Matthew Richard
Format Patent
LanguageEnglish
Published 25.03.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:wherein R1, R2, and R3 are defined herein, their use as branched-chain alpha keto acid dehydrogenase kinase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetes, NASH and heart failure.
Bibliography:Application Number: US202017078257